Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Neuraxis Inc NRXS

Healthcare
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It... see more

Current News (NYSEAM:NRXS)

NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway

GlobeNewswire January 8, 2026

NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives

GlobeNewswire December 19, 2025

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

GlobeNewswire December 1, 2025

NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives

GlobeNewswire November 12, 2025

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

GlobeNewswire November 11, 2025

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

GlobeNewswire November 4, 2025

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

GlobeNewswire October 24, 2025

NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

GlobeNewswire September 18, 2025

NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues

GlobeNewswire August 12, 2025
View More News ››

Opinion & Analysis (NYSEAM:NRXS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:NRXS)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - December 19, 2025

Buy buddy buy. for

Otherwise FOMO for you fellas out there anyway, so good luck to all of you guys
coolfooldumbguy - October 24, 2025

Buy buddy buy.

Otherwise you guys out there will be missing out on this stock this morning
coolfooldumbguy - May 20, 2025
View more Bullboard ››

Lipari Mining Ltd.

Lipari Mining Ltd.

Lipari Mining is a natural diamond producer from its 100% owned Braúna diamond mine in Brazil. The Braúna mine is the only ...
View More »

Podcasts